UCLA can do the moderate trial very quickly. But t
Post# of 148185
Looking at the recent update on the severely ill patient phase 2b/3 trial it was interesting to see that the number of recruiting sites was not increased. Only Montefiore still mentioned.
Looks like Dr. Yang (UCLA) prefers EIND above the severe trial?
gf